IVD Quality Control Market Assessment, By Source [Plasma, Whole Blood, Urine], By Product [Quality Control Products, Data Management Solutions, Quality Assessment Services], By Application [Oncology, Cardiology, Neurology, Infectious Diseases, Autoimmune Disorders, Others], By Technique [Molecular Diagnostics, Coagulation/Hemostasis, Hematology, Microbiology, Immunochemistry/Immunoassay, Clinical Chemistry/Biochemistry, Others], By End-user [Hospitals and Clinics, Diagnostic Laboratories, IVD Manufacturers, CROs, Others], By Region, Opportunities and Forecast, 2017-2031F
The IVD quality control market is expected to grow because of increasing emphasis on data management and connectivity.
Home>Industry Reports>Global IVD Quality Control Market Assessment, Opportunities and Forecast, 2017-2031F
Global IVD quality control market is projected to witness a CAGR of 4.77% during the forecast period 2024-2031F, growing from USD 1.32 billion in 2023 to USD 1.91 billion in 2031F. Various factors shape the global IVD quality control market, including an increased focus on developing new and innovative products, increased integration of advanced technologies, rise in demand for immunoassay products, increased popularity of data management solutions, and dominance of North America.
Several factors are controlling the global IVD quality control market, including fostering innovations and developing new products. Manufacturers are always trying to create new and better disposable surgical instruments that will increase surgical efficiency, patient safety, and affordability. This requires investigating cutting-edge components, styles, and features to satisfy the changing demands of the medical field. The global IVD quality control market is integrating cutting-edge technology, including artificial intelligence, data management systems, and automation. These technological developments enhance the precision, effectiveness, and accessibility of quality control procedures in diagnostic testing.
The global IVD quality control market is anticipated to be dominated by the immunoassay/immunochemistry segment. This is because an increasing variety of immunoassay tests are available, which offer quick, easy, and precise findings for target identification and quantification. Since they make data storage, processing, and reporting more efficient, data management systems are becoming increasingly popular in the global IVD quality control industry. These technologies facilitate data integrity, increase overall operational efficiency, and simplify quality control procedures for laboratories.
For example, a global leader in clinical diagnostic products and life science research, Bio-Rad Laboratories, Inc., announced in September 2023 the introduction of its PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, intended to facilitate polymerase chain reaction (PCR) applications in basic and translational research, process development, and quality control. The newest models in Bio-Rad's traditional PCR heat cyclers lineup are the PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers. The PTC Tempo Thermal Cyclers are designed with an updated, user-friendly interface and adaptable connectivity options, including the ability to monitor data on the BR.io cloud platform to streamline protocol administration.
Increased Focus on Developing PCR Tests in the Market
The global IVD quality control market is witnessing an increased focus on the development of PCR tests. Applications and methods for polymerase chain reaction have been created, refined, and employed in the last several years for a variety of clinical fields. The creation of quality standards for these new PCR methods has been necessary to comply with both good laboratory practice (GLP) and (inter)national guidelines, as is the case with any "in-house" assay whose results impact clinical decision-making. Quality standards have previously been established for "classical" diagnostic tests like ELISAs and culture-based assays, and there are also established recommendations for both quality assurance and quality control for new PCR-based assays that are constantly being developed and improved.
For example, the GENE-UP BREWPRO Yeast Slurry (YS) is a novel diagnostic quality control PCR test that was introduced in May 2024 by bioMérieux, Inc., a global leader in in vitro diagnostics. Its purpose is to precisely identify impurities in raw yeast materials and yeast propagations to guarantee fermentation of the highest caliber. The solution, which was created in partnership with White Labs, has specialized targets designed specifically for yeast slurries and an optimized sample prep with higher sensitivity. Present-day brewing industry quality control test kits are made to identify possible spoilers in the final product rather than in the yeast slurries themselves.
Increased Integration of Advanced Technologies is Driving the Market
Innovation is essential for improving quality control, and the tremendous transition in the diagnostics industry is bolstering the growth of the global IVD quality control market. The diagnosis procedure is being completely transformed by cutting-edge technology, including automation, machine learning, and artificial intelligence. These developments have the potential to increase the precision, effectiveness, and dependability of quality control procedures, producing test results that are more reliable and consistent. The diagnostics industry's quality control procedures have seen a substantial transformation because of the incorporation of Internet of Things (IoT) technologies. Diagnostic tools with IoT capabilities may continually track several variables, including equipment performance, humidity, and temperature. Proactive quality control procedures are made possible by the quick detection of any deviations from ideal operating conditions made possible by this real-time data collection.
For example, Bio-Rad Laboratories Inc. revealed in August 2023 that they will leverage AWS Systems Manager to build an Internet of Things device that will enhance their Next-Generation Quality Control Informatics Solution. AWS Systems Manager is a comprehensive and secure resource management tool that can be used in hybrid and multi-cloud scenarios. Without requiring any extra IT support, it connects to the instrument, the lab information system, middleware, and other software through an edge device that serves as a bridge between the lab and the cloud.
The Rise in Demand for Immunoassay Products is Boosting Market Growth
Immunoassay products are an important part of the global IVD quality control market. IVD kits and reagent variance are evaluated and tracked using immunoassay-based quality control tools. Any variations in performance can be found and fixed by comparing several IVD products to standardized immunoassay controls. Immunoassay-based quality control products can be used to identify the cause of problems in diagnostic testing. Potential causes of error, such as reagent quality, instrument performance, or operator technique, can be found and fixed by comparing results from control samples to predicted values.
For instance, Siemens Healthineers AG introduced Atellica CI Analyzer, a small testing equipment designed to address lab problems, in July 2023. With its unique features, the Atellica CI Analyzer is carefully built to maximize downtime and boost lab productivity and profitability. Labs can provide more consistent sample turnaround times thanks to automated maintenance and quality control scheduling, micro-volume aspiration, and random-access sampling. The independence of the immunoassay and chemistry engines ensures that throughput is unaffected if one of them needs to stop.
Data Management Solutions are Popular in the Market
Data management solutions offer a centralized platform for storing, organizing, and managing all data about quality control procedures in the IVD industry. In this way, a single source for quality control data is produced, incorporating information from several diagnostic devices, laboratory information systems (LIS), and other locations. Data management systems offer safe data storage, access controls, and audit trails to guarantee the accuracy and traceability of quality control data. Real-time monitoring of quality control parameters, including test results, reagent stability, and equipment performance, can be facilitated by data management solutions. All these factors make data management solutions an important factor driving the growth of the global IVD quality control market.
For instance, with the introduction of new waters_connect for IVD and QUAN Review Application in May 2024, Waters Corporation simplified the clinical data review process. ExceptionFocused Review (xfR) enables users to quickly identify and address errors that require attention. Its key features include reducing data review time by up to 50% (in comparison to Waters TargetLyn Software) and providing a one-screen dashboard that summarizes key parameters like standards, calibration, and quality control, all grouped for a streamlined view.
North America is Dominating the IVD Quality Control Market
The global IVD quality control market is dominated by North American nations, especially the United States, for several important reasons, including the existence of several accredited clinical laboratories. The United States boasts a well-respected healthcare system and many accredited clinical laboratories that follow tight quality control guidelines. The healthcare systems in North America have embraced cutting-edge diagnostic technologies like immunoassays and molecular diagnostics with great speed. The requirement for quality control procedures to guarantee the precision and dependability of test results has increased because of the growing usage of these technologies.
For example, Next Gen Diagnostics announced on June 11, 2024, that it would open its first laboratory in the United States in Cambridge, Massachusetts. The facility will offer United States’ customers and partners fully integrated, affordable bacterial sequencing and bioinformatics services. This ability is enhanced by NGD's best-in-class fully automated bioinformatics, which offers comprehensive analysis of cohort phylogeny, resistance elements, and phenotype, delivered and visualized in a robust user interface, as well as quality control and relatedness determination validated in several publications.
Future Market Scenario (2024-2031F)
1. The global IVD quality control market is expected to see a rise in demand for multi-analyte controls, which contain numerous analytes of interest.
2. Point-of-care testing adoption in the global IVD quality control market is motivated by the need for quick, easy-to-use, and trustworthy diagnostic tools that improve patient outcomes and expedite processes.
3. It is anticipated that the increased focus on developing environmentally friendly and sustainable products will drive the growth of the global IVD quality control market.
4. In the global IVD quality control market, companion diagnostics, which direct the use of particular treatment products, are becoming increasingly popular.
Report Scope
“IVD Quality Control Market Assessment, Opportunities, and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, that provides an in-depth analysis and qualitative and quantitative assessment of the current state of the global IVD quality control market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, opportunities, and forecasts between 2024 and 2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031F |
|
Projected Growth Rate |
CAGR of 4.77% between 2024 and 2031F |
|
Revenue Forecast in 2031 |
USD 1.91 billion |
|
Segments Covered |
Source, Product, Application, Technique, End-user |
|
Regions Covered |
North America, Europe, South America, Asia-Pacific, Middle East and Africa |
|
Key Companies Profile |
Bio-Rad Laboratories Inc., Danaher Corporation, Thermo Fisher Scientific Inc., QuidelOrtho Corporation, Siemens Healthineers AG, LGC Group, Randox Laboratories Ltd., Microbiologics, Inc., Streck LLC, SERO AS |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfill your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, the global IVD quality control market has been segmented into the following categories:
:
o Plasma
o Whole Blood
o Urine
· By Product
o Quality Control Products
· By Function
ú Instrument-Specific Controls
ú Independent Controls
· By Type
ú Serum/Plasma-based Controls
ú Whole Blood-based Controls
ú Urine-based Controls
ú Others
o Data Management Solutions
o Quality Assessment Services
o Oncology
o Cardiology
o Neurology
o Infectious Diseases
o Autoimmune Disorders
o Others
· By Technique
o Molecular Diagnostics
o Coagulation/Hemostasis
o Hematology
o Microbiology
o Immunochemistry/Immunoassay
o Clinical Chemistry/Biochemistry
o Others
· By End-user
o Hospitals and Clinics
o Diagnostic Laboratories
o IVD Manufacturers
o CROs
o Others
· By Region
o North America
o Europe
o Asia-Pacific
o South America
Middle East and Africa
Key Players Landscape and Outlook
Many major companies in the global IVD quality control market are forming alliances to expand in the industry. Major players can build more sophisticated and comprehensive quality control products by collaborating with other businesses to make use of complementary skills, technology, and resources. Through alliances, prominent players can better serve the different needs of the diagnostics industry by broadening the scope of their quality control solutions and diversifying their product portfolios. Investing heavily in R&D and obtaining regulatory licenses is necessary to develop products with quality control.
For example, top AI software provider Bioz, Inc., dedicated to scientific research, announced in January 2024 that it has partnered with top worldwide diagnostics provider Randox Laboratories Ltd. The organization, which is well-known for its creative research and development, provides a wide range of superior goods and services, such as quality controls, toxicology solutions, modern diagnostic devices, and clinical chemistry reagents. Using this creative partnership, Bioz has integrated Bioz Badges as dynamic, real-time widgets into the product pages of Randox Laboratories' website. These widgets offer real-time scientific application data, including excerpts from peer-reviewed scientific articles that are specifically connected to the use of the product. This collaboration aims to help academics make evidence-based decisions by raising exposure and brand awareness.
Key Players Operating in the Global IVD Quality Control Market are:
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- QuidelOrtho Corporation
- Siemens Healthineers AG
- LGC Group
- Randox Laboratories Ltd.
- Microbiologics, Inc.
- Streck LLC
- SERO AS
Markets and Data’s reports answer the following questions:
- What is the current and future market size of the product/service in question globally or specific to different countries?
- How are the markets divided into different product/service segments and the market size and growth of each segment?
- What is the market potential of different product segments and their investment case?
- How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
- What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for the global IVD quality control market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope and Definitions
3. Executive Summary
4. Global IVD Quality Control Market Outlook, 2017-2031F
4.1. Market Size & Forecast
4.1.1.By Value
4.1.2.By Volume
4.2. By Product
4.2.1.By Source
4.2.1.1. Plasma
4.2.1.2. Whole Blood
4.2.1.3. Urine
4.2.2.Quality Control Products
4.2.2.1. By Function
4.2.2.1.1. Instrument-Specific Controls
4.2.2.1.2. Independent Controls
4.2.2.2. By Type
4.2.2.2.1. Serum/Plasma-based Controls
4.2.2.2.2. Whole Blood-based Controls
4.2.2.2.3. Urine-based Controls
4.2.2.2.4. Others
4.2.3.Data Management Solutions
4.2.4.Quality Assessment Services
4.3. By Application
4.3.1.Oncology
4.3.2.Cardiology
4.3.3.Neurology
4.3.4.Infectious Diseases
4.3.5.Autoimmune Disorders
4.3.6.Others
4.4. By Technique
4.4.1.Molecular Diagnostics
4.4.2.Coagulation/Hemostasis
4.4.3.Hematology
4.4.4.Microbiology
4.4.5.Immunochemistry/Immunoassay
4.4.6.Clinical Chemistry/Biochemistry
4.4.7.Others
4.5. By End-user
4.5.1.Hospitals and Clinics
4.5.2.Diagnostic Laboratories
4.5.3.IVD Manufacturers
4.5.4.CROs
4.5.5.Others
4.6. By Region
4.6.1.North America
4.6.2.Europe
4.6.3.Asia-Pacific
4.6.4.South America
4.6.5.Middle East and Africa
4.7. By Company Market Share (%), 2023
5. Global IVD Quality Control Market Outlook, By Region, 2017-2031F
5.1. North America*
5.1.1.Market Size & Forecast
5.1.1.1. By Value
5.1.1.2. By Volume
5.1.2.By Source
5.1.2.1. Plasma
5.1.2.2. Whole Blood
5.1.2.3. Urine
5.1.3.By Product
5.1.3.1. Quality Control Products
5.1.3.1.1. By Function
5.1.3.1.1.1. Instrument-Specific Controls
5.1.3.1.1.2. Independent Controls
5.1.3.1.2. By Type
5.1.3.1.2.1. Serum/Plasma-based Controls
5.1.3.1.2.2. Whole Blood-based Controls
5.1.3.1.2.3. Urine-based Controls
5.1.3.1.2.4. Others
5.1.3.2. Data Management Solutions
5.1.3.3. Quality Assessment Services
5.1.4.By Application
5.1.4.1. Oncology
5.1.4.2. Cardiology
5.1.4.3. Neurology
5.1.4.4. Infectious Diseases
5.1.4.5. Autoimmune Disorders
5.1.4.6. Others
5.1.5.By Technique
5.1.5.1. Molecular Diagnostics
5.1.5.2. Coagulation/Hemostasis
5.1.5.3. Hematology
5.1.5.4. Microbiology
5.1.5.5. Immunochemistry/Immunoassay
5.1.5.6. Clinical Chemistry/Biochemistry
5.1.5.7. Others
5.1.6.By End-user
5.1.6.1. Hospitals and Clinics
5.1.6.2. Diagnostic Laboratories
5.1.6.3. IVD Manufacturers
5.1.6.4. CROs
5.1.6.5. Others
5.1.7.United States*
5.1.7.1. Market Size & Forecast
5.1.7.1.1. By Value
5.1.7.1.2. By Volume
5.1.7.2. By Source
5.1.7.2.1. Plasma
5.1.7.2.2. Whole Blood
5.1.7.2.3. Urine
5.1.7.3. By Product
5.1.7.3.1. Quality Control Products
5.1.7.3.1.1. By Function
5.1.7.3.1.1.1. Instrument-Specific Controls
5.1.7.3.1.1.2. Independent Controls
5.1.7.3.2. By Type
5.1.7.3.2.1.1. Serum/Plasma-based Controls
5.1.7.3.2.1.2. Whole Blood-based Controls
5.1.7.3.2.1.3. Urine-based Controls
5.1.7.3.2.1.4. Others
5.1.7.3.3. Data Management Solutions
5.1.7.3.4. Quality Assessment Services
5.1.7.4. By Application
5.1.7.4.1. Oncology
5.1.7.4.2. Cardiology
5.1.7.4.3. Neurology
5.1.7.4.4. Infectious Diseases
5.1.7.4.5. Autoimmune Disorders
5.1.7.4.6. Others
5.1.7.5. By Technique
5.1.7.5.1. Molecular Diagnostics
5.1.7.5.2. Coagulation/Hemostasis
5.1.7.5.3. Hematology
5.1.7.5.4. Microbiology
5.1.7.5.5. Immunochemistry/Immunoassay
5.1.7.5.6. Clinical Chemistry/Biochemistry
5.1.7.5.7. Others
5.1.7.6. By End-user
5.1.7.6.1. Hospitals and Clinics
5.1.7.6.2. Diagnostic Laboratories
5.1.7.6.3. IVD Manufacturers
5.1.7.6.4. CROs
5.1.7.6.5. Others
5.1.8.Canada
5.1.9.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. Asia-Pacific
5.3.1.India
5.3.2.China
5.3.3.Japan
5.3.4.Australia
5.3.5.Vietnam
5.3.6.South Korea
5.3.7.Indonesia
5.3.8.Philippines
5.4. South America
5.4.1.Brazil
5.4.2.Argentina
5.5. Middle East and Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Source
6.2. By Product
6.3. By Application
6.4. By Technique
6.5. By End-user
6.6. By Region
7. Macro Environment and Industry Structure
7.1. Demand Supply Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
7.4.1.Political Factors
7.4.2.Economic System
7.4.3.Social Implications
7.4.4.Technological Advancements
7.4.5.Environmental Impacts
7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1.Supplier Power
7.5.2.Buyer Power
7.5.3.Substitution Threat
7.5.4.Threat From New Entrant
7.5.5.Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Bio-Rad Laboratories, Inc.
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products and Services
13.1.4. Financials (As Reported)
13.1.5. Key Market Focus and Geographical Presence
13.1.6. Recent Developments
13.3. Thermo Fisher Scientific, Inc.
13.4. QuidelOrtho Corporation
13.5. Siemens Healthineers AG
13.6. LGC Group
13.7. Randox Laboratories Ltd.
13.8. Microbiologics, Inc.
13.9. Streck LLC
13.10. SERO AS
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figures
Figure 1. Global IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 3. Global IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 4. Global IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 5. Global IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 6. Global IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 7. Global IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 8. Global IVD Quality Control Market Share (%), By Region, 2017-2031F
Figure 9. North America IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 10. North America IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 11. North America IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 12. North America IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 13. North America IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 14. North America IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 15. North America IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 16. North America IVD Quality Control Market Share (%), By Country, 2017-2031F
Figure 17. United States IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 18. United States IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 19. United States IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 20. United States IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 21. United States IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 22. United States IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 23. United States IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 24. Canada IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 25. Canada IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 26. Canada IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 27. Canada IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 28. Canada IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 29. Canada IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 30. Canada IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 31. Mexico IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 32. Mexico IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 33. Mexico IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 34. Mexico IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 35. Mexico IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 36. Mexico IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 37. Mexico IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 38. Europe IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 39. Europe IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 40. Europe IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 41. Europe IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 42. Europe IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 43. Europe IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 44. Europe IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 45. Europe IVD Quality Control Market Share (%), By Country, 2017-2031F
Figure 46. Germany IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 47. Germany IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 48. Germany IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 49. Germany IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 50. Germany IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 51. Germany IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 52. Germany IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 53. France IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 54. France IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 55. France IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 56. France IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 57. France IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 58. France IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 59. France IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 60. Italy IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 61. Italy IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 62. Italy IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 63. Italy IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 64. Italy IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 65. Italy IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 66. Italy IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 67. United Kingdom IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 68. United Kingdom IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 69. United Kingdom IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 70. United Kingdom IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 71. United Kingdom IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 72. United Kingdom IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 73. United Kingdom IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 74. Russia IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 75. Russia IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 76. Russia IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 77. Russia IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 78. Russia IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 79. Russia IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 80. Russia IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 81. Netherlands IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 82. Netherlands IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 83. Netherlands IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 84. Netherlands IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 85. Netherlands IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 86. Netherlands IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 87. Netherlands IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 88. Spain IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 89. Spain IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 90. Spain IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 91. Spain IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 92. Spain IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 93. Spain IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 94. Spain IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 95. Turkey IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 96. Turkey IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 97. Turkey IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 98. Turkey IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 99. Turkey IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 100. Turkey IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 101. Turkey IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 102. Poland IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 103. Poland IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 104. Poland IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 105. Poland IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 106. Poland IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 107. Poland IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 108. Poland IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 109. South America IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 110. South America IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 111. South America IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 112. South America IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 113. South America IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 114. South America IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 115. South America IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 116. South America IVD Quality Control Market Share (%), By Country, 2017-2031F
Figure 117. Brazil IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 118. Brazil IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 119. Brazil IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 120. Brazil IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 121. Brazil IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 122. Brazil IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 123. Brazil IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 124. Argentina IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 125. Argentina IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 126. Argentina IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 127. Argentina IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 128. Argentina IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 129. Argentina IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 130. Argentina IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 131. Asia-Pacific IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 132. Asia-Pacific IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 133. Asia-Pacific IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 134. Asia-Pacific IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 135. Asia-Pacific IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 136. Asia-Pacific IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 137. Asia- Pacific IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 138. Asia-Pacific IVD Quality Control Market Share (%), By Country, 2017-2031F
Figure 139. India IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 140. India IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 141. India IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 142. India IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 143. India IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 144. India IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 145. India IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 146. China IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 147. China IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 148. China IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 149. China IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 150. China IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 151. China IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 152. China IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 153. Japan IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 154. Japan IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 155. Japan IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 156. Japan IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 157. Japan IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 158. Japan IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 159. Japan IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 160. Australia IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 161. Australia IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 162. Australia IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 163. Australia IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 164. Australia IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 165. Australia IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 166. Australia IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 167. Vietnam IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 168. Vietnam IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 169. Vietnam IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 170. Vietnam IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 171. Vietnam IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 172. Vietnam IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 173. Vietnam IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 174. South Korea IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 175. South Korea IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 176. South Korea IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 177. South Korea IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 178. South Korea IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 179. South Korea IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 180. South Korea IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 181. Indonesia IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 182. Indonesia IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 183. Indonesia IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 184. Indonesia IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 185. Indonesia IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 186. Indonesia IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 187. Indonesia IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 188. Philippines IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 189. Philippines IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 190. Philippines IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 191. Philippines IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 192. Philippines IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 193. Philippines IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 194. Philippines IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 195. Middle East & Africa IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 196. Middle East & Africa IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 197. Middle East & Africa IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 198. Middle East & Africa IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 199. Middle East & Africa IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 200. Middle East & Africa IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 201. Middle East & Africa IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 202. Middle East & Africa IVD Quality Control Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 204. Saudi Arabia IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 205. Saudi Arabia IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 206. Saudi Arabia IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 207. Saudi Arabia IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 208. Saudi Arabia IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 209. Saudi Arabia IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 210. UAE IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 211. UAE IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 212. UAE IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 213. UAE IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 214. UAE IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 215. UAE IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 216. UAE IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 217. South Africa IVD Quality Control Market, By Value, In USD Billion, 2017-2031F
Figure 218. South Africa IVD Quality Control Market, By Volume, In Million Units, 2017-2031F
Figure 219. South Africa IVD Quality Control Market Share (%), By Source, 2017-2031F
Figure 220. South Africa IVD Quality Control Market Share (%), By Product, 2017-2031F
Figure 221. South Africa IVD Quality Control Market Share (%), By Application, 2017-2031F
Figure 222. South Africa IVD Quality Control Market Share (%), By Technique, 2017-2031F
Figure 223. South Africa IVD Quality Control Market Share (%), By End-user, 2017-2031F
Figure 224. By Source Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 225. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227. By Technique Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What regions are covered in the final report for the global IVD quality control market?
Who are the key players operating in the global IVD quality control market?
What are the major drivers influencing the growth of the global IVD quality control market?
What is the market size and growth rate of the global IVD quality control market?
See Related Reports
India Construction Equipment Market Assessment, Opportunities and Forecast, FY2018-FY2032F
India construction equipment market is expected to experience growth due to increasing investment in infrastructure development, enhancement in the construction sector, technological advancement in construction equipment, and rising production of ele....Read More
Published on
August 2024
3,300
Global Mobile Crusher and Screener Market Assessment, Opportunities and Forecast, 2017-2031F
The global mobile crusher and screener market is driven by new mining and construction activities, new crushing technology, faster mobility, high-end research and development, and electric mobility.....Read More
Published on
August 2024
4,500
Saudi Arabia Generic Drugs Market Assessment, Opportunities and Forecast, 2017-2031F
The growth of the Saudi Arabia generic drugs market is boosted by the growing awareness about generic drugs, rising prevalence of chronic diseases, and increasing efforts of the market players to support the launch of biosimilars in the country.....Read More
Published on
August 2024
3,300
South Korea Generic Drugs Market Assessment, Opportunities and Forecast, 2017-2031F
The growth of the South Korea generic drugs market is supported by the increasing patent expiration for various drugs in the coming years and the rising efforts of the government to reduce the costs of generics.....Read More
Published on
August 2024
3,300
Purchase Options
USD ($)
i
2,760
3,000
8%
i
4,050
4,500
10%
i
5,016
5,700
12%
i
6,970
8,200
15%
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
